Effect of multidisciplinary refined time management combined with organized stroke management on the efficacy of intravenous thrombolysis in patients with acute ischemic stroke

This study aims to investigate the effects of multidisciplinary refined time management combined with organized stroke management in intravenous thrombolysis on patients with acute ischemic stroke. 226 acute ischemic stroke patients treated with intravenous thrombolysiswere selected for retrospective analysis. A Control group participants underwent organized stroke management, whereas study group participants underwent multidisciplinary refined time management based on the control group. The study group responded to intravenous thrombolysis for 24 hours at an overall rate of 92.92%, significantly higher than 79.65% in the control group (p < 0.05). The time from onset to emergency, time for National Institute of Health Stroke Scale (NIHSS) scoring by emergency doctors, consultation time for neurologists, judgement time for head computed tomography (CT), interpretation time for examination results, communication time with family members to sign the consent form, and time from admission to medication in the study group were significantly shorter than that in control group (p < 0.05). The incidence of hemorrhagic transformation, six-month mortality and six-month rehospitalization rate in the study group were significantly lower than those in the control group (p < 0.05). Before thrombolysis, cerebrovascular reserve function and neurological function indexes in both groups were improved, and there was significant difference before and after thrombolysis in this group (p > 0.05); After thrombolysis, mean blood flow velocity (MFV) and breath-holding index (BHI) in the study group were significantly higher than those in the control group (p < 0.05); pulsatility index (PI) was lower than that in the control group, showing a significant difference (p < 0.05); Serum nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) were significantly higher than those in the control group (p < 0.05). Multidisciplinary refined time management combined with organized stroke management can improve the effect of intravenous thrombolysis in acute ischemic stroke.

Multidisciplinary refinement; Time management; Organized stroke management; Acute ischemic stroke; Intravenous thrombolysis

[1] Duvekot MHC, Venema E, Kerkhoff H, Dippel DWJ, Roozenbeek B. Prehospital scales in acute ischaemic stroke management— Authors’ reply. The Lancet Neurology. 2021; 20: 504–505.

[2] Dziewas R. Nutrition in acute stroke management: food for thought. The Lancet Neurology. 2022; 21: 296–297.

[3] Turc G, Hadziahmetovic M, Walter S, Churilov L, Larsen K, Grotta JC, et al. Comparison of mobile stroke unit with usual care for acute ischemic stroke management. JAMA Neurology. 2022; 79: 281–290.

[4] Yan LL, Gong E, Gu W, Turner EL, Gallis JA, Zhou Y, et al. Effectiveness of a primary care-based integrated mobile health intervention for stroke management in rural China (SINEMA): a cluster-randomized controlled trial. PLOS Medicine. 2021; 18: e1003582.

[5] Chavva IR, Crawford AL, Mazurek MH, Yuen MM, Prabhat AM, Payabvash S, et al. Deep learning applications for acute stroke management. Annals of Neurology. 2022; 92: 574–587.

[6] Payne T, Moran B, Loadsman J, Marschner I, McCulloch T, Sanders RD. Importance of sequential methods in meta-analysis: implications for postoperative mortality, delirium, and stroke management. British Journal of Anaesthesia. 2023; 130: 395–401.

[7] Kamal N, Lakshminarayan K. Simulation and machine learning provide new approaches to examine quality of acute stroke management. Stroke. 2022; 53: 2768–2769.

[8] Hajdu SD, Marto JP, Saliou G. Response by Hajdu et al to letter regarding article, “Acute stroke management during the COVID-19 pandemic: does confinement impact eligibility for endovascular therapy?”. Stroke. 2020; 51: e340–e341.

[9] Kwan J, Lobotesis K, Banerjee S. Letter by Kwan et al regarding article, “Acute stroke management during the COVID-19 pandemic: does confinement impact eligibility for endovascular therapy?”. Stroke. 2020; 51: e338–e339.

[10] Fousse M, Grün D, Helwig SA, Walter S, Bekhit A, Wagenpfeil S, et al. Effects of a feedback-demanding stroke clock on acute stroke management: a randomized study. Stroke. 2020; 51: 2895–2900.

[11] Bonura A, Motolese F, Capone F, Iaccarino G, Alessiani M, Ferrante M, et al. Smartphone app in stroke management: a narrative updated review. Journal of Stroke. 2022; 24: 323–334.

[12] Bonura A, Motolese F, Capone F, Iaccarino G, Alessiani M, Ferrante M, et al. Smartphone app in stroke management: a narrative updated review. Journal of Stroke. 2023; 25: 320–324.

[13] Li H, Lam WC, Guo J, Zheng J, Cheung CH, Bian Z, et al. A framework on developing integrative medicine clinical practice guideline for stroke management and rehabilitation in Hong Kong. Phytomedicine. 2022; 106: 154442.

[14] Hollist M, Morgan L, Cabatbat R, Au K, Kirmani MF, Kirmani BF. Acute stroke management: overview and recent updates. Aging and Disease. 2021; 12: 1000–1009.

[15] Markus HS. Stroke subtypes and outcomes in China, common clinical conundrums in stroke management, and pediatric stroke. International Journal of Stroke. 2023; 18: 762–764.

[16] Brown DL, Durkalski V, Durmer JS, Broderick JP, Zahuranec DB, Levine DA, et al. Sleep for stroke management and recovery trial (Sleep SMART): rationale and methods. International Journal of Stroke. 2020; 15: 923–929.

[17] Lip GYH, Ntaios G. “Novel clinical concepts in thrombosis”: integrated care for stroke management—easy as ABC. Thrombosis and Haemostasis. 2022; 122: 316–319.

[18] Bandini F, Vestito L, Filippi L. Prehospital scales in acute ischaemic stroke management. The Lancet Neurology. 2021; 20: 504.